Literature DB >> 32621758

Sponsor-involved statistical analyses in Phase III cancer clinical trials.

Joseph Abi Jaoude1, Ramez Kouzy1, Bruce D Minsky1, Clifton David Fuller1, Ying Yuan1, Kim-Anh Do1, Cullen M Taniguchi1, Ethan B Ludmir1.   

Abstract

Entities:  

Keywords:  FDA; biostatistician; clinical trials; industry; oncology

Mesh：

Year:  2020        PMID： 32621758      PMCID： PMC8460289          DOI： 10.1002/ijc.33180

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

1.  Relationship between conflicts of interest and research results.

Authors:  Lee S Friedman; Elihu D Richter
Journal:  J Gen Intern Med       Date:  2004-01       Impact factor: 5.128

2.  Best practice for statisticians in industry sponsored trials.

Authors:  Steven A Julious; Stephen Pyke; Sara Hughes
Journal:  BMJ       Date:  2011-03-15

3.  Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.

Authors:  Ethan B Ludmir; Walker Mainwaring; Timothy A Lin; Austin B Miller; Amit Jethanandani; Andres F Espinoza; Jacob J Mandel; Steven H Lin; Benjamin D Smith; Grace L Smith; Noam A VanderWalde; Bruce D Minsky; Albert C Koong; Thomas E Stinchcombe; Reshma Jagsi; Daniel R Gomez; Charles R Thomas; C David Fuller
Journal:  JAMA Oncol       Date:  2019-12-01       Impact factor: 31.777

4.  ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.

Authors:  Lisa M Schwartz; Steven Woloshin; Eugene Zheng; Tony Tse; Deborah A Zarin
Journal:  Ann Intern Med       Date:  2016-06-14       Impact factor: 25.391

5.  Conflict of interest in academic oncology: moving beyond the blame game and forging a path forward.

Authors:  V Prasad; S V Rajkumar
Journal:  Blood Cancer J       Date:  2016-11-04       Impact factor: 11.037

6.  Why do you need a biostatistician?

Authors:  Antonia Zapf; Geraldine Rauch; Meinhard Kieser
Journal:  BMC Med Res Methodol       Date:  2020-02-05       Impact factor: 4.615
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.